Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03005379 · ClinicalTrials.gov registry record · Phase 2
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
A Phase 2 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 2
- Development phase
- 153
- Enrollment target
NCT03005379: Clinical Trial Phase 2 study, sponsored by VA Office of Research and Development.
NCT03005379 is a Phase 2 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03005379, a Phase 2 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Fecal Microbiota Therapy (FMT) is effective vs. placebo in the prevention of C. difficile infection recurrence.
Interventions
- DRUG Placebo
- DRUG Fecal Microbiota Therapy (FMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2023-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03005379
The ClinicalTrials.gov registry entry for NCT03005379 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03005379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03005379 about?
NCT03005379 is a clinical study titled "Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)". The purpose of this study is to determine whether Fecal Microbiota Therapy (FMT) is effective vs. placebo in the prevention of C. difficile infection recurrence.
What is the current status of trial NCT03005379?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 153 participants. The study started on 2018-11-15. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03005379?
The interventions under investigation include: Placebo (DRUG), Fecal Microbiota Therapy (FMT) (DRUG).
Who is sponsoring clinical trial NCT03005379?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.